| Followers | 240 |
| Posts | 15523 |
| Boards Moderated | 1 |
| Alias Born | 03/29/2014 |
Saturday, July 20, 2024 3:05:05 PM
I understand how you can come to the conclusions you're suggesting. For my part, I am quite sure that what Nem says happened to him (the diagnosis, the surgery, the suggestion at some point of the trial), happened. So rather then flat out accuse him of lying, being a short, and all the other numerous things people have called him here, I'd rather take the sympathetic side, for the most part, because to some degree, I feel he is deserving of it. Additionally, no one else has offered any sympathies towards him... making us all look, well, not so great, and rather unkind IMO. And I think in most of our hearts of hearts, you would be somewhat more sympathetic to what happened to him, if you believed him. Of course, I don't think Northwest played any part in this whatsoever, and of course, all of us know that the patients who were enrolled in the trial legitimately had GBM, and it's rather insulting to their memories to suggest otherwise.
Believe me, I understand why others might think he's lying about all of this, and creating some sort of nefarious persona, as we've seen others do, much like Pyhrr did, on multiple occasions. But I don't believe he is, so there's that.
As far as our discussions driving down the price... perhaps, but I doubt it. I don't think the shorts think Nem's thinking that the whole trial is a sham and that people without GBM and without tumors were entered into the trial to receive a vaccine that simply couldn't even be made. My concerns, frankly, were that Nem was implying that his complaints had moved past NICE and MHRA, whom I personally think have probably listened, looked into, and disagreed with his concerns. And if moving past those concerns is moving on to Paul Mulholland at the CHM, who has indicated his hope for the future of GBM treatment with DCVax-L, then my concerns are alleviated. And accusing Dr. Mulholland of some sort of malfeasance in taking trips on NWBO's dime for the presentation, he's not doing himself any favors to that end.
Believe me, I understand why others might think he's lying about all of this, and creating some sort of nefarious persona, as we've seen others do, much like Pyhrr did, on multiple occasions. But I don't believe he is, so there's that.
As far as our discussions driving down the price... perhaps, but I doubt it. I don't think the shorts think Nem's thinking that the whole trial is a sham and that people without GBM and without tumors were entered into the trial to receive a vaccine that simply couldn't even be made. My concerns, frankly, were that Nem was implying that his complaints had moved past NICE and MHRA, whom I personally think have probably listened, looked into, and disagreed with his concerns. And if moving past those concerns is moving on to Paul Mulholland at the CHM, who has indicated his hope for the future of GBM treatment with DCVax-L, then my concerns are alleviated. And accusing Dr. Mulholland of some sort of malfeasance in taking trips on NWBO's dime for the presentation, he's not doing himself any favors to that end.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
